Skip to main content

Market Overview

Why This General Electric Analyst Is Bullish On Heels Of GE Healthcare Spinoff

Share:
Why This General Electric Analyst Is Bullish On Heels Of GE Healthcare Spinoff

Earlier this month, General Electric Company (NYSE: GE) announced plans to spin off its healthcare business.

GE Healthcare Holding LLC (GEHC) remains on track to trade independently on April 1, 2023, according to Oppenheimer.

The Analyst: Christopher Glynn upgraded the rating for General Electric to Outperform, while keeping the price target unchanged at $104.

Check out other analyst stock ratings.

The Thesis: There is strong momentum in aviation, with a recovery in the aerospace industry, Glynn said.

General Electric has exhibited “strong execution amidst widespread industry supply-chain challenges impacting the commercial business and internal production challenges serving military markets,” the analyst added. "At Power, consistent and broad-based profitability improvement affirms intact turnaround trajectory/runway, even if mediocre absolute profitability as yet."

“Potential catalysts include LTC/insurance separation and sustained growth break-out at $4.2B/'22E military."

GE Price Action: Shares of General Electric had risen by 1.52% to $85.95 in pre-market trading on Tuesday.

Next: GE Reports Pricing Of $8.25 Billion Debt Offerings

 

Related Articles (GE)

View Comments and Join the Discussion!

Posted-In: Christopher Glynn OppenheimerAnalyst Color News Upgrades Top Stories Analyst Ratings

Latest Ratings

StockFirmActionPT
SEDGB of A SecuritiesMaintains411.0
PTLOPiper SandlerMaintains28.0
AOUTLake StreetMaintains26.0
RAPTPiper SandlerMaintains52.0
OCXLake StreetMaintains6.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com